Money / Martin Shkreli Company Shkreli Wanted to Turn Around Files for Chapter 11 KaloBios Pharmaceuticals is still appealing its Nasdaq delisting By Jenn Gidman Posted Dec 30, 2015 8:22 AM CST Copied Back